185 related articles for article (PubMed ID: 27600661)
1. Determinants of treatment-related paradoxical reactions during anti-tuberculosis therapy: a case control study.
Brown CS; Smith CJ; Breen RA; Ormerod LP; Mittal R; Fisk M; Milburn HJ; Price NM; Bothamley GH; Lipman MC
BMC Infect Dis; 2016 Sep; 16(1):479. PubMed ID: 27600661
[TBL] [Abstract][Full Text] [Related]
2. Variation in C - reactive protein response according to host and mycobacterial characteristics in active tuberculosis.
Brown J; Clark K; Smith C; Hopwood J; Lynard O; Toolan M; Creer D; Barker J; Breen R; Brown T; Cropley I; Lipman M
BMC Infect Dis; 2016 Jun; 16():265. PubMed ID: 27287260
[TBL] [Abstract][Full Text] [Related]
3. Factors influencing treatment default among tuberculosis patients in a high burden province of South Africa.
Kigozi G; Heunis C; Chikobvu P; Botha S; van Rensburg D
Int J Infect Dis; 2017 Jan; 54():95-102. PubMed ID: 27894985
[TBL] [Abstract][Full Text] [Related]
4. Determinants for tuberculosis in HIV-infected adults in Northwest Ethiopia: a multicentre case-control study.
Alemu YM; Awoke W; Wilder-Smith A
BMJ Open; 2016 Apr; 6(4):e009058. PubMed ID: 27084271
[TBL] [Abstract][Full Text] [Related]
5. Anakinra in the treatment of protracted paradoxical inflammatory reactions in HIV-associated tuberculosis in the United Kingdom: a report of two cases.
Keeley AJ; Parkash V; Tunbridge A; Greig J; Collini P; McKane W; Tattersall RS
Int J STD AIDS; 2020 Jul; 31(8):808-812. PubMed ID: 32631210
[TBL] [Abstract][Full Text] [Related]
6. Unsuccessful TB treatment outcomes with a focus on HIV co-infected cases: a cross-sectional retrospective record review in a high-burdened province of South Africa.
Engelbrecht MC; Kigozi NG; Chikobvu P; Botha S; van Rensburg HCJ
BMC Health Serv Res; 2017 Jul; 17(1):470. PubMed ID: 28693508
[TBL] [Abstract][Full Text] [Related]
7. Paradoxical response during anti-tuberculosis treatment in HIV-negative patients with pulmonary tuberculosis.
Cheng SL; Wang HC; Yang PC
Int J Tuberc Lung Dis; 2007 Dec; 11(12):1290-5. PubMed ID: 18034948
[TBL] [Abstract][Full Text] [Related]
8. Paradoxical reactions during tuberculosis treatment in patients with and without HIV co-infection.
Breen RA; Smith CJ; Bettinson H; Dart S; Bannister B; Johnson MA; Lipman MC
Thorax; 2004 Aug; 59(8):704-7. PubMed ID: 15282393
[TBL] [Abstract][Full Text] [Related]
9. Healthcare provision for HIV co-infected tuberculosis patients in rural Zambia: an observational cohort study at primary care centers.
Miyano S; Muvuma S; Ishikawa N; Endo H; Msiska C; Syakantu G
BMC Health Serv Res; 2013 Oct; 13():397. PubMed ID: 24103082
[TBL] [Abstract][Full Text] [Related]
10. Converging risk factors but no association between HIV infection and multidrug-resistant tuberculosis in Kazakhstan.
van den Hof S; Tursynbayeva A; Abildaev T; Adenov M; Pak S; Bekembayeva G; Ismailov S
Int J Tuberc Lung Dis; 2013 Apr; 17(4):526-31. PubMed ID: 23485387
[TBL] [Abstract][Full Text] [Related]
11. Anti-tuberculosis drug induced hepatotoxicity among TB/HIV co-infected patients at Jimma University Hospital, Ethiopia: nested case-control study.
Hassen Ali A; Belachew T; Yami A; Ayen WY
PLoS One; 2013; 8(5):e64622. PubMed ID: 23696901
[TBL] [Abstract][Full Text] [Related]
12. The burden of HIV on Tuberculosis patients in the Volta region of Ghana from 2012 to 2015: implication for Tuberculosis control.
Osei E; Der J; Owusu R; Kofie P; Axame WK
BMC Infect Dis; 2017 Jul; 17(1):504. PubMed ID: 28724359
[TBL] [Abstract][Full Text] [Related]
13. The burden and treatment of HIV in tuberculosis patients in Papua Province, Indonesia: a prospective observational study.
Pontororing GJ; Kenangalem E; Lolong DB; Waramori G; Sandjaja ; Tjitra E; Price RN; Kelly PM; Anstey NM; Ralph AP
BMC Infect Dis; 2010; 10():362. PubMed ID: 21605474
[TBL] [Abstract][Full Text] [Related]
14. Tuberculosis associated mortality in a prospective cohort in Sub Saharan Africa: Association with HIV and antiretroviral therapy.
Nagu TJ; Aboud S; Mwiru R; Matee MI; Rao M; Fawzi WW; Zumla A; Maeurer MJ; Mugusi F
Int J Infect Dis; 2017 Mar; 56():39-44. PubMed ID: 28161460
[TBL] [Abstract][Full Text] [Related]
15. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
API Consensus Expert Committee
J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
[TBL] [Abstract][Full Text] [Related]
16. Major genotype families and epidemic clones of Mycobacterium tuberculosis in Omsk region, Western Siberia, Russia, marked by a high burden of tuberculosis-HIV coinfection.
Pasechnik O; Vyazovaya A; Vitriv S; Tatarintseva M; Blokh A; Stasenko V; Mokrousov I
Tuberculosis (Edinb); 2018 Jan; 108():163-168. PubMed ID: 29523319
[TBL] [Abstract][Full Text] [Related]
17. Treatment outcome of HIV-associated tuberculosis in a resource-poor setting.
Ifebunandu NA; Ukwaja KN; Obi SN
Trop Doct; 2012 Apr; 42(2):74-6. PubMed ID: 22431822
[TBL] [Abstract][Full Text] [Related]
18. Factors associated with tuberculosis treatment delay in patients co-infected with HIV in a high prevalence area in Brazil.
Nogueira BMF; Rolla VC; Akrami KM; Kiene SM
PLoS One; 2018; 13(4):e0195409. PubMed ID: 29624603
[TBL] [Abstract][Full Text] [Related]
19. Effect of Inflammatory Cytokines/Chemokines on Pulmonary Tuberculosis Culture Conversion and Disease Severity in HIV-Infected and -Uninfected Individuals From South Africa.
Rambaran S; Naidoo K; Lewis L; Hassan-Moosa R; Govender D; Samsunder N; Scriba TJ; Padayatchi N; Sivro A
Front Immunol; 2021; 12():641065. PubMed ID: 33868272
[TBL] [Abstract][Full Text] [Related]
20. Incidence and risk factors of serious adverse events during antituberculous treatment in Rwanda: a prospective cohort study.
Lorent N; Sebatunzi O; Mukeshimana G; Van den Ende J; Clerinx J
PLoS One; 2011; 6(5):e19566. PubMed ID: 21611117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
